Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin's lymphoma
- Type
- Retraction
- Notice date
- 4/27/2022 0:00
- Journal
- European Journal of Haematology
- Publisher
- Wiley
- Notice DOI
- 10.1111/ejh.13776
- Original paper DOI
- 10.1111/ejh.13279